Treatment of Late-life Anxiety in Primary Care Settings

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Wake Forest Baptist Health
ClinicalTrials.gov Identifier:
NCT00938093
First received: July 10, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
  Purpose

The research study proposed is designed to examine the outcomes of a cognitive behavioral guided self-care intervention with older adults diagnosed with generalized anxiety disorder and recruited from a primary care setting. It is hypothesized that the cognitive behavioral guided self-care intervention will produce greater declines in worry and anxiety than enhanced usual care.


Condition Intervention Phase
Generalized Anxiety Disorder
Panic Disorder
Anxiety Disorder Not Otherwise Specified
Behavioral: Cognitive behavioral therapy
Behavioral: Enhanced usual care
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Treatment of Late-life Anxiety in Primary Care Settings

Resource links provided by NLM:


Further study details as provided by Wake Forest Baptist Health:

Enrollment: 60
Study Start Date: March 2006
Study Completion Date: February 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Cognitive behavioral therapy
    Participants receive 10 telephone therapy sessions and an accompanying workbook focused on cognitive-behavioral techniques for managing anxiety.
    Behavioral: Enhanced usual care
    Participants receive written information about anxiety, referrals for treatment, and an optional letter to their primary care physician.
  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age ≥ 60 years
  • a DSM-IV diagnosis of GAD
  • able to read English.

Exclusion Criteria:

  • current psychotherapy
  • a DSM-IV diagnosis of alcohol or substance abuse
  • a diagnosis of dementia or global cognitive impairment operationalized as a score of < 24 of the Mini-Mental Status Examination
  • psychotic symptoms
  • active suicidal ideation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Gretchen A. Brenes, Ph.D. Associate Professor, Wake Forest Univeristy School of Medicine
ClinicalTrials.gov Identifier: NCT00938093     History of Changes
Other Study ID Numbers: MH65281, MH65281
Study First Received: July 10, 2009
Last Updated: July 10, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Anxiety Disorders
Disease
Panic Disorder
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on October 22, 2014